# PharmaLegacy
> PharmaLegacy is a preclinical CRO with 1,500+ validated in vivo efficacy models across 100+ indications, including non-human primate and humanized rodent models. Labs in Shanghai and San Diego (BioLegacy Research). PK/PD, DMPK, in vitro, histopathology, biomarkers, and medical device testing.

Human site: https://www.pharmalegacy.com — Markdown mirrors append .md to the page path. PDF text mirrors append .md to the PDF URL. Contact: info@pharmalegacy.com. US +1-617-803-9415. Shanghai +86-21-6176-5100 ext. 8051. Addresses: Jinqiao Free Trade Zone, Shanghai; 6042 Cornerstone Court W, Suite E, San Diego, CA 92121.

## Start here

- [Home](https://www.pharmalegacy.com/index.md): Preclinical CRO overview: 1,500+ models, 100+ indications, Shanghai and San Diego labs.
- [About Us](https://www.pharmalegacy.com/about-us.md): How PharmaLegacy differs: models, NHP capacity, AAALAC, IND support.
- [Services](https://www.pharmalegacy.com/services.md): Pharmacology platforms: PK/PD, DMPK, in vitro, biomarkers, histopathology, NHP, devices.
- [Indications](https://www.pharmalegacy.com/indications.md): Disease-area index for translational animal models.
- [All Models](https://www.pharmalegacy.com/all-models.md): Searchable catalog of in vivo and in vitro models.
- [NHP Models & NHP Studies](https://www.pharmalegacy.com/nhp-models-nhp-studies.md): Non-human primate capacity, sourcing, and model list.
- [Contact](https://www.pharmalegacy.com/contact-us.md): Shanghai and San Diego addresses, phone, and email.

## Services

- [Pharmacokinetics and Pharmacodynamics (PK/PD)](https://www.pharmalegacy.com/services/pharmacokinetics-and-pharmacodynamics-pk-pd.md): PK/PD and candidate screening / IND package support.
- [DMPK](https://www.pharmalegacy.com/services/dmpk.md): ADME, PK, bioanalysis, and non-GLP toxicology.
- [In Vitro Efficacy and Safety Testing](https://www.pharmalegacy.com/services/in-vitro-platform.md): Cell-based, IO, ADC, kinase, GPCR, and safety assays.
- [Biomarker Discovery & Detection](https://www.pharmalegacy.com/services/biomarker-detection.md): Biomarker and in vitro immunization assays.
- [Histopathology](https://www.pharmalegacy.com/services/histopathology.md): Histopathology and histomorphometry.
- [Medical Device Testing](https://www.pharmalegacy.com/services/medical-device-testing.md): Bone/dental, cardiovascular, cerebrovascular, and other devices.
- [Non-Human Primate Studies](https://www.pharmalegacy.com/services/non-human-primate-studies.md): NHP platforms across immunology, metabolism, ophthalmology, and more.

## Indications

- [Oncology / Immuno-Oncology](https://www.pharmalegacy.com/indications/oncology-immuno-oncology.md): CDX, syngeneic, humanized, ADC, and metastasis models.
- [Inflammation, Immunity & Autoimmunity](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity.md): Arthritis, colitis, SLE, psoriasis, GVHD, and related models.
- [Neuroscience Models](https://www.pharmalegacy.com/indications/cns-disease-models.md): Neurodegenerative, neuropsychiatric, seizure, and sleep models.
- [Cardiovascular Disease Models](https://www.pharmalegacy.com/indications/cardiovascular-disease-models.md): Heart failure, stroke, thrombosis, and related models.
- [Hepatic & Renal Disease Models](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models.md): MASH/MASLD, fibrosis, CKD, and related models.
- [Ocular Disease Models](https://www.pharmalegacy.com/indications/ophthalmic-disease-models.md): AMD, glaucoma, dry eye, gene therapy, and related models.
- [Otology / Auditory Models](https://www.pharmalegacy.com/indications/otology.md): Hearing impairment and ototoxicity studies.
- [Pain & Analgesia Models](https://www.pharmalegacy.com/indications/pain-models.md): Nociceptive, inflammatory, neuropathic, and visceral pain.
- [Metabolic Disease Models](https://www.pharmalegacy.com/indications/metabolic-disease-models.md): Diabetes, obesity, hyperlipidemia, hyperuricemia.
- [Musculoskeletal Models](https://www.pharmalegacy.com/indications/bone-orthopedics.md): Bone repair, OA, osteoporosis, and related models.
- [Respiratory Disease Models](https://www.pharmalegacy.com/indications/pulmonology-lung-disease-models.md): Asthma, IPF, cough, and lung inflammation.
- [Infectious Diseases](https://www.pharmalegacy.com/indications/infectious-diseases.md): Infectious-disease model work.

## Company

- [Partners](https://www.pharmalegacy.com/partners.md): Frontage, Tigermed, and HMT partnerships.
- [News](https://www.pharmalegacy.com/news.md): Press, acquisitions, and conference notes.
- [Brochures](https://www.pharmalegacy.com/brochures.md): Brochure and case-study index (gated PDF downloads).
- [Careers](https://www.pharmalegacy.com/join-us/careers.md): Open positions.
- [Privacy Policy](https://www.pharmalegacy.com/privacy-policy.md): Privacy policy.
- [Preclinical Oncology CRO](https://www.pharmalegacy.com/preclinical-oncology-cro.md): Oncology CRO landing page.
- [Drug Discovery CRO](https://www.pharmalegacy.com/drug-discovery-cro.md): Discovery-stage CRO landing page.
- [Drug Development CRO](https://www.pharmalegacy.com/drug-development-cro.md): Development-stage CRO landing page.
- [Preclinical Research CRO](https://www.pharmalegacy.com/preclinical-research-cro.md): General preclinical CRO landing page.

## Documents

- [Immuno-oncology case study](https://www.pharmalegacy.com/wp-content/uploads/2023/04/Immuno-Oncology-Case-Study.pdf.md): Top-20 pharma IO case study (public Media Library PDF).

## Pages

- [Acute Kidney Disease](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models/acute-kidney-disease.md)
- [Acute Nociceptive Pain](https://www.pharmalegacy.com/indications/pain-models/nociceptive-pain.md)
- [ADC In Vitro Evaluation](https://www.pharmalegacy.com/services/in-vitro-platform/adc-in-vitro-evaluation.md)
- [Allergy & Hypersensitivity](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/allergy-hypersensitivity.md)
- [Alzheimer’s Disease Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/alzheimers-disease.md)
- [Amyotrophic Lateral Sclerosis Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/als-models.md)
- [Antibody-Drug Conjugate Characterization & Evaluation](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/adc-characterization-evaluation.md)
- [Arthritis](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/arthritis.md)
- [Asthma](https://www.pharmalegacy.com/indications/pulmonology-lung-disease-models/asthma.md)
- [BaF3 Assays](https://www.pharmalegacy.com/services/in-vitro-platform/baf3-assays.md)
- [Bioanalysis](https://www.pharmalegacy.com/services/dmpk/bioanalysis.md)
- [Biomarkers and Pharmacodynamics Analysis](https://www.pharmalegacy.com/services/in-vitro-platform/biomarkers-and-pharmacodynamics-analysis.md)
- [Blogs](https://www.pharmalegacy.com/blog.md)
- [Bone / Dental Devices](https://www.pharmalegacy.com/services/medical-device-testing/bone-dental.md)
- [Bone Defect & Bone Repair Studies](https://www.pharmalegacy.com/indications/bone-orthopedics/bone-defect-bone-repair-studies.md)
- [Bone Metastasis](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/bone-metastasis.md)
- [Bone Safety Studies](https://www.pharmalegacy.com/indications/bone-orthopedics/bone-safety-studies.md)
- [Candidate Screening / IND package](https://www.pharmalegacy.com/services/pharmacokinetics-and-pharmacodynamics-pk-pd/candidate-screening-ind-package.md)
- [Cardio-Renal Syndrome](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models/cardio-renal-syndrome.md)
- [Cardio-Renal Syndrome](https://www.pharmalegacy.com/indications/cardiovascular-disease-models/cardio-renal-syndrome.md)
- [Cardiovascular Devices](https://www.pharmalegacy.com/services/medical-device-testing/cardiovascular-devices.md)
- [Cartilage Tissue Repair](https://www.pharmalegacy.com/indications/bone-orthopedics/cartilage-tissue-repair.md)
- [Cell Based Assays – Immuno-Oncology](https://www.pharmalegacy.com/services/in-vitro-platform/cell-based-assays-immuno-oncology.md)
- [Cell Differentiation / Polarization Assay](https://www.pharmalegacy.com/services/in-vitro-platform/cell-differentiation-polarization-assay.md)
- [Cell-based Assays – Cytotoxicity](https://www.pharmalegacy.com/services/in-vitro-platform/cell-based-assay-cytotoxicity.md)
- [Cell-based Assays – Immune Modulator](https://www.pharmalegacy.com/services/in-vitro-platform/cell-based-assays-immune-modulator.md)
- [Cerebrovascular Devices](https://www.pharmalegacy.com/services/medical-device-testing/cerebrovascular-devices.md)
- [Chronic Kidney Disease](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models/chronic-kidney-disease.md)
- [Colitis](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/colitis.md)
- [Corneal Diseases](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/corneal-diseases.md)
- [Corporate Culture](https://www.pharmalegacy.com/about-us/corporate-culture.md)
- [Cough](https://www.pharmalegacy.com/indications/pulmonology-lung-disease-models/cough.md)
- [Diabetes Mellitus](https://www.pharmalegacy.com/indications/metabolic-disease-models/diabetes-mellitus.md)
- [Diabetic Retinopathy](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/diabetic-retinopathy.md)
- [Doctor-Operated Devices](https://www.pharmalegacy.com/services/medical-device-testing/doctor-operated-devices.md)
- [Dry AMD / Geographic Atrophy](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/dry-amd.md)
- [Dry Eye](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/dry-eye.md)
- [Ex-Vivo Tumor Studies](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/ex-vivo-tumor-studies.md)
- [Flow Cytometry / FACS](https://www.pharmalegacy.com/services/in-vitro-platform/facs.md)
- [General Inflammation](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/general-inflammation.md)
- [Glaucoma / Neuroprotection](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/glaucoma.md)
- [GPCR Assays](https://www.pharmalegacy.com/services/in-vitro-platform/gpcr-assays.md)
- [Graft-Versus-Host Disease](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/graft-versus-host-disease.md)
- [Greeting from our CEO](https://www.pharmalegacy.com/about-us/greeting-from-our-ceo.md)
- [Hearing Impairment Models](https://www.pharmalegacy.com/indications/otology/hearing-impairment-models.md)
- [Heart Failure](https://www.pharmalegacy.com/indications/cardiovascular-disease-models/heart-failure.md)
- [Hematology & Thrombosis](https://www.pharmalegacy.com/services/non-human-primate-studies/hematology-thrombosis.md)
- [Hemorrhage / Hemostasis](https://www.pharmalegacy.com/indications/cardiovascular-disease-models/hemorrhage-hemostasis.md)
- [Histomorphometry](https://www.pharmalegacy.com/services/histopathology/histomorphometry.md)
- [Histopathology](https://www.pharmalegacy.com/services/histopathology/histopathology.md)
- [Human Cancer Cell Panel](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/human-cancer-cell-panel.md)
- [Humanized Mouse Models](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/humanized-mouse-models.md)
- [Hyperuricemia](https://www.pharmalegacy.com/indications/metabolic-disease-models/hyperuricemia.md)
- [Immune-Response Related Hepatitis](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models/immune-response-related-hepatitis.md)
- [In Vitro ADME Assays](https://www.pharmalegacy.com/services/dmpk/adme.md)
- [In Vitro Immunization](https://www.pharmalegacy.com/services/biomarker-detection/in-vitro-immunization.md)
- [In vitro Otology Studies](https://www.pharmalegacy.com/indications/otology/in-vitro-otology-studies.md)
- [In vitro Testing Studies](https://www.pharmalegacy.com/services/non-human-primate-studies/in-vitro-testing-studies.md)
- [Inflammation, Immune & Autoimmune Diseases](https://www.pharmalegacy.com/services/non-human-primate-studies/inflammation-immune-autoimmune-diseases.md)
- [Inflammatory Pain](https://www.pharmalegacy.com/indications/pain-models/inflammatory-pain.md)
- [Inflammatory Pain Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/aging-studies.md)
- [Key Instruments](https://www.pharmalegacy.com/services/in-vitro-platform/key-instruments.md)
- [Kinase/Enzyme Assays](https://www.pharmalegacy.com/services/in-vitro-platform/kinase-enzyme-assays.md)
- [Large Molecule PK and ADA](https://www.pharmalegacy.com/services/in-vitro-platform/large-molecule-pk-and-ada.md)
- [Ligament / Tendon Repair Studies](https://www.pharmalegacy.com/indications/bone-orthopedics/ligament-tendon-repair-studies.md)
- [Liver Fibrosis & Cirrhosis](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models/liver-fibrosis-cirrhosis.md)
- [MASH / MASLD](https://www.pharmalegacy.com/indications/hepatic-renal-disease-models/nafld-nash.md)
- [Metabolic Disease Models](https://www.pharmalegacy.com/services/non-human-primate-studies/metabolic-disease-models.md)
- [Migraine](https://www.pharmalegacy.com/indications/pain-models/migraine.md)
- [Migraines and Pain Models](https://www.pharmalegacy.com/indications/cns-disease-models/migraines-and-pain.md)
- [Migraines Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/spinal-muscular-atrophy.md)
- [Multiple Sclerosis Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/huntingtons-disease-models.md)
- [Myopia / Presbyopia](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/myopia-presbyopia.md)
- [Neurodegenerative Disease Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases.md)
- [Neuroinflammation](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/neuroinflammation.md)
- [Neuropathic Pain](https://www.pharmalegacy.com/indications/pain-models/neuropathic-pain.md)
- [Neuropathic Pain Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/rett-syndrome-models.md)
- [Neuropsychiatric Disease Models](https://www.pharmalegacy.com/indications/cns-disease-models/neuropsychiatric-diseases.md)
- [Nude Rat Models](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/nude-rat-models.md)
- [Obesity and Hyperlipidemia](https://www.pharmalegacy.com/indications/metabolic-disease-models/obesity-and-hyperlipidemia.md)
- [Ocular Gene Therapy](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/ocular-gene-therapy.md)
- [Ophthalmology Models](https://www.pharmalegacy.com/services/non-human-primate-studies/ophthalmology-models.md)
- [Orthopedics Models](https://www.pharmalegacy.com/services/non-human-primate-studies/orthopedics-models.md)
- [Osteoarthritis Models](https://www.pharmalegacy.com/indications/bone-orthopedics/osteoarthritis-models.md)
- [Osteomyelitis Models](https://www.pharmalegacy.com/indications/bone-orthopedics/osteomyelitis-models.md)
- [Osteoporosis Models](https://www.pharmalegacy.com/indications/bone-orthopedics/osteoporosis-models.md)
- [Other NHP Models & Studies](https://www.pharmalegacy.com/services/non-human-primate-studies/other-nhp-models-studies.md)
- [Other Pain Models](https://www.pharmalegacy.com/indications/cns-disease-models/neuropsychiatric-diseases/anxiety-fear.md)
- [Others](https://www.pharmalegacy.com/services/medical-device-testing/others.md)
- [Ototoxicity Studies](https://www.pharmalegacy.com/indications/otology/ototoxicity-studies.md)
- [Parkinson’s Disease Models](https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/parkinsons-disease-models.md)
- [PK](https://www.pharmalegacy.com/services/dmpk/pk.md)
- [Pneumonitis / Acute Lung Inflammation](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/pneumonitis-acute-lung-inflammation.md)
- [Pneumonitis / Acute Lung Inflammation](https://www.pharmalegacy.com/indications/pulmonology-lung-disease-models/pneumonitis-acute-lung-inflammation.md)
- [Postoperative Pain](https://www.pharmalegacy.com/indications/pain-models/postoperative-pain.md)
- [Preclinical Seizure Studies](https://www.pharmalegacy.com/indications/cns-disease-models/seizure-studies.md)
- [Preclinical Studies of Depression](https://www.pharmalegacy.com/indications/cns-disease-models/neuropsychiatric-diseases/depression.md)
- [Proliferative Vitreoretinopathy (PVR)](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/proliferative-vitreoretinopathy-pvr.md)
- [Psoriasis](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/psoriasis.md)
- [Pterygium](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/pterygium.md)
- [Pulmonary Fibrosis & IPF](https://www.pharmalegacy.com/indications/pulmonology-lung-disease-models/pulmonary-fibrosis.md)
- [Retinal Arteriovenous Malformations (AVMs)](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/avms.md)
- [Retinal Vein Occlusion](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/retinal-vein-occlusion.md)
- [Safety Assays](https://www.pharmalegacy.com/services/in-vitro-platform/safety-assays.md)
- [Schizophrenia Models](https://www.pharmalegacy.com/indications/cns-disease-models/neuropsychiatric-diseases/schizophrenia.md)
- [Sepsis](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/sepsis.md)
- [Sleep Disorder Studies](https://www.pharmalegacy.com/indications/cns-disease-models/sleep-disorder-studies.md)
- [Stroke](https://www.pharmalegacy.com/indications/cardiovascular-disease-models/stroke.md)
- [Stroke Models](https://www.pharmalegacy.com/indications/cns-disease-models/neuropsychiatric-diseases/addiction.md)
- [Subretinal Fibrosis](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/subretinal-fibrosis.md)
- [Syngeneic Mouse Models](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/syngeneic-mouse-models.md)
- [Systemic Lupus Erythematosus](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/systemic-lupus-erythematosus.md)
- [Thrombosis](https://www.pharmalegacy.com/indications/cardiovascular-disease-models/thrombosis.md)
- [Thyroid Eye Disease](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/thyroid-eye-disease.md)
- [Toxicology](https://www.pharmalegacy.com/services/dmpk/toxicology.md)
- [Uveitis / Conjunctivitis](https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/uveitis-conjunctivitis.md)
- [Uveitis / Conjunctivitis](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/uveitis.md)
- [Vaccine Evaluation](https://www.pharmalegacy.com/services/in-vitro-platform/vaccine-evaluation.md)
- [Visceral Pain](https://www.pharmalegacy.com/indications/pain-models/visceral-pain.md)
- [Wet AMD](https://www.pharmalegacy.com/indications/ophthalmic-disease-models/wet-amd.md)
- [Xenograft Mouse Models](https://www.pharmalegacy.com/indications/oncology-immuno-oncology/xenograft-mouse-models.md)

## Articles

- [Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories](https://www.pharmalegacy.com/catawba-research-announces-strategic-partnership-with-pharmalegacy-laboratories.md)
- [PharmaLegacy acquires preclinical CRO BTS Research, strengthening its preclinical services and expanding laboratory operations into North America](https://www.pharmalegacy.com/pharmalegacy-acquires-preclinical-cro-bts-research-strengthening-its-preclinical-services-and-expanding-laboratory-operations-into-north-america.md)
- [PHARMALEGACY ATTENDING BIO-EUROPE SPRING MARCH 18-20, 2024 IN SPAIN](https://www.pharmalegacy.com/pharmalegacy-attending-bio-europe-spring-march-18-20-2024-in-spain.md)
- [PharmaLegacy Contributes to World’s First Gene Therapy for Hereditary Deafness](https://www.pharmalegacy.com/pharmalegacy-contributes-to-worlds-first-gene-therapy-for-hereditary-deafness.md)
- [PharmaLegacy Reaffirms the Source of its Non-Human Primates](https://www.pharmalegacy.com/pharmalegacy-reaffirms-the-source-of-its-non-human-primates.md)
- [PharmaLegacy to Exhibit at AACR 2022 April 10 – 13 in New Orleans](https://www.pharmalegacy.com/aacr-2022.md)
- [PHARMALEGACY TO EXHIBIT AT AACR APRIL 14-19, 2023 IN FLORIDA](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aacr-april-14-19-2023-in-florida.md)
- [PHARMALEGACY TO EXHIBIT AT AACR APRIL 7-10, 2024 IN CALIFORNIA](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aacr-april-7-10-2024-in-california.md)
- [PharmaLegacy to exhibit at ARVO April 23-27 2023 in Louisiana](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-arvo-april-23-27-2023-in-louisiana.md)
- [PHARMALEGACY TO EXHIBIT AT ARVO MAY 5-9 2024 IN SEATTLE, WASHINGTON](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-arvo-may-5-9-in-seattle-washington.md)
- [PHARMALEGACY TO EXHIBIT AT BIO-EUROPE 2024 NOVEMBER 4-6 2024 IN STOCKHOLM SWEDEN](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-bio-europe-2024-november-4-6-2024-in-stockholm-sweden.md)
- [PHARMALEGACY TO EXHIBIT AT BIOTECH SUMMIT 2024 OCTOBER 10-11 2024 IN INNSBRUCK, AUSTRIA](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-biotech-summit-2024-october-10-11-2024-in-innsbruck-austria.md)
- [PHARMALEGACY TO EXHIBIT AT NLS DAYS 2024 SEPTEMBER 18-19 2024 IN MALMÖ, SWEDEN](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-nls-days-2024-september-18-19-2024-in-malmo-sweden.md)
- [PharmaLegacy to Exhibit at SITC 2022 in Boston](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-sitc-2022-in-boston.md)
- [PharmaLegacy to exhibit at ToxExpo March 11-13 2024 in Utah](https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-toxexpo-march-11-13-2024-in-utah.md)